Anti-Human ALB & TNFA Recombinant Antibody
-
产品编号
YR1259
-
别名
科研级 Ozoralizumab ( 奥利组单抗 ), Anti-ALB & TNFA Recombinant Antibody, Research Grade Ozoralizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Ozoralizumab ( 奥利组单抗 ), Anti-ALB & TNFA Recombinant Antibody, Research Grade Ozoralizumab |
| Catalog Number | YR1259 |
| Molecular Name | Ozoralizumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | VH-VH'-VH |
| Formulation | PBS, pH7.5 |
| Background | Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases. Ozoralizumab was developed by Pfizer Inc, and now belongs to Ablynx NV. Ablynx has licensed the rights to the antibody in China to Eddingpharm. |
| CAS Number | 1167985-17-2 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | ALB & TNFA[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
